Medicare Will Limit Coverage of Controversial $28,000/Year Alzheimer’s Drug; One Clinical Trial Patient Has Already Died
By B.N. Frank In July, the Food and Drug Administration (FDA) approved an Alzheimer’s drug that May not be safe or effective Would cost $56,000/year…